Editorial Board

Editors (4)

Prof. Dr. Samuel C. Mok
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: gynecologic cancers; tumor microenvironment; diagnostic and prognostic biomarkers discovery; stomal-epithelial interaction; exosomes
Special Issues and Collections in MDPI journals
Prof. Dr. David Wong
Associate Editor-in-Chief
Director, Center for Oral/Head & Neck Oncology Research, School of Dentistry, Felix & Mildred Yip Endowed Professor & Associate Dean of Research, University of California Los Angeles, 10833 Le Conte Avenue, 73-034 CHS, Los Angeles CA 90095, USA
Interests: oral cancer; salivary diagnostics; salivaomics; liquid biopsy; early detection
Special Issues and Collections in MDPI journals
Prof. Mary Frances McMullin
Associate Editor-in-Chief
Centre for Medical Education, Queen's University, Belfast, UK
Interests: myeloproliferative disorders; polycythaemia vera; idiopathic erythrocytosis; acute myeloid leukaemia; chronic myeloid leukaemia; clinical trials
Dr. Deepak Nagrath
Associate Editor-in-Chief
Department of Biomedical Engineering, Department of Chemical Engineering, University of Michigan, NCRC, Bldg 28, Room 3048W, 2800 Plymouth Rd, Ann Arbor, MI 48109, USA
Interests: cancer metabolism; tumor microenvironment; metabolic profiling; systems biology; metabolomics
Special Issues and Collections in MDPI journals

Previous Editor

Prof. Dr. Robert H. Weiss *
Former Editor-in-Chief
Division of Nephrology and Cancer Center, University of California, Davis, CA 95616, USA; and Nephrology Section, Sacramento VAMC; and NCI Early Detection Research Network (EDRN), USA
Interests: cyclins and cyclin inhibitors; cancer growth control; metabolomics and proteomics; polycystic kidney disease
* Editor-in-Chief from 2009 to 2015

Editorial Board Members (1032)

Prof. Dr. Amir Abdollahi
1. Division of Molecular and Translational Radiation Oncology, Heidelberg University Hospital (UKHD) Heidelberg Ion-Beam Therapy Center (HIT) Im Neuenheimer Feld 450 and Clinical Cooperation Unit Translational Oncology, 69120 Heidelberg, Germany
2. Cancer Consortium (DKTK), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany
Interests: tumor evolution; translational research; radiation oncology; particle therapy; personalized oncology; tumor-stroma-communication; antiangiogenic therapy; tumor resistance
Prof. Dr. Ghassan Abou-Alfa
1. Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
2. Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA
Interests: liver cancer; HCC; cholangiocarcinoma; gallbaldder cancer; biliary cancer
Prof. Dr. Roger Abounader
Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22903, USA
Interests: brain Tumor; glioma; medulloblastoma; non-coding RNA; microRNA; calcium channel; receptor tyrosine kinase; p53; PTEN; signal transduction
Prof. Dr. Dietmar Abraham
Division of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, A-1090 Vienna, Austria
Interests: tumor-host interaction; tumor microenvironment; tumor-associated macrophage; signal transduction; tumor angiogenesis; CSF-1; IL-34; tumor invasion and metastasis; preclinical cancer therapeutics
Special Issues and Collections in MDPI journals:
Dr. Elisabetta Abruzzese

Hematology, S. Eugenio Hospital, Tor Vergata University, ASL ROma2, 00144 Rome, Italy
Interests: Chronic Myeloid Leukema; Tyrosin kinase inhibitors in hematologic diseases (CML, ALL, mastocytosis, hypereosinophilia); myeloproliferative disorders; myelofibrosis; Hodgkin lymphoma; aggressive non -Hodgkin Lymphomas; pregnancy in hematologic diseases
Dr. Farrukh Afaq
Department of Dermatology, The University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA
Interests: cancer chemoprevention; photocarcinogenesis; melanoma; targeted therapies; psoriasis; biochemical toxicology; cell signaling pathways
Prof. Dr. Abbas Agaimy
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany
Interests: head & neck cancer with focus on salivary gland and sinonasal tract neoplasms; GI stromal tumors (GIST) with focus on molecular progression pathways, therapy effects and drug resistance; GI & pancreatobiliary cancer with focus on neuroendocrine and poorly differentiated/dedifferentiated neoplasms; soft tissue tumors/sarcoma; undifferentiated malignancies with focus on dedifferentiated melanoma; hereditary tumor syndromes with focus on neurofibromatosis type 1 & hereditary GI & urological cancer syndromes; SWI/SNF-deficient neoplasia with focus on the role of SWI/SNF complex in the initiation, progression and dedifferentiation of neoplasms of different organs
Prof. Dr. Massimo Aglietta
Department of Medical Oncology, Candiolo Cancer Institute, FPO—IRCCS—Str. Prov.le 142, km 3.95, 10060 Candiolo (TO), Italy
Interests: Sarcoma, gastrointestinal cancers, early clinical trials
Special Issues and Collections in MDPI journals:
Dr. Aamir Ahmad

University of Alabama at Birmingham, Birmingham, AL, USA
Interests: cancer epigenetics; metastasis; cancer drug resistance; tumor microenvironment; miRNA; non-coding RNAs; cancer stem cells
Special Issues and Collections in MDPI journals:
Prof. Dr. Myung-Ju Ahn

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul135-710, Korea
Interests: lung cancer; head and neck cancer; translational research; targeted agents; immunotherapy; molecular biology
Back to TopTop